VAERS reports by lot

Moderna COVID-19 lot 002821A: VAERS reports

48 VAERS reports list lot 002821A as a Moderna COVID-19 vaccine, received between 2021-03-04 and 2022-09-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
48
Reports
8%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5424%
Musculoskeletal4219%
Neurological3315%
Gastrointestinal2511%
Cardiac / Cardiovascular2210%
Respiratory136%
Injection-site / Local reaction125%
Dermatological (non-injection-site)104%
Allergic / Anaphylactic73%
Thrombotic / Hematological21%
Autoimmune / Immune-mediated21%
Psychiatric / Neuropsychiatric21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan8
Connecticut4
Florida4
Pennsylvania3
Texas3
Virginia3
Alabama3
New York3
Georgia2
Oklahoma2
South Carolina2
California1

Reports by month received

2021-0317
2021-046
2021-054
2021-063
2021-0811
2021-091
2021-101
2021-122
2022-011
2022-071
2022-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.